Wednesday, Mar 16, 2022 | 2:00 PM ET
Has Virtual Care Revived the Future of Disease Management?
We’re at an inflection point in the evolution of disease management. In the early 2000’s, it felt as though disease management programs were dead on arrival –– especially after the Congressional Budget Office drew the conclusion that they did not generate any favorable return on investment (ROI) for Medicare beneficiaries. Fast forward 20 years and now the world of healthcare is completely different. Uptake of virtual care has been significant — a majority of healthcare consumers are receiving at least some care virtually — and technology makes an integrated approach across clinical disciplines not just viable, but optimal. Much has changed in the world since the early aughts, and so has disease management.
In this discussion, healthcare delivery leaders across various lines of insured business will share how the evolution of disease management has led to improved clinical outcomes, along with a real, measurable ROI.
Join us to discover why:
- Commercial, Managed Medicaid, and Medicare populations can all benefit from effective disease management
- New disease management programs focused on mental + physical health will succeed where previous, narrowly focused models failed
- Virtual interactions allow for greater scale and ROI
Alex KnappSenior Editor, Forbes
Dr. Linda HotchkissFmr. Managing Medical Director, Anthem
Richard FrankSVP - Medical Affairs, Vida
Harlan Levine, M.D.President, Health Innovation and Policy, City of Hope